TrialDrugs in R&D2025
Demonstrating Bioequivalence for a Lumacaftor Monosubstance Formulation Versus Orkambi
Alexandra Papaelias et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
TrialDrugs in R&D2025
Alexandra Papaelias et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.